Home › Research › Disease mechanisms
The spleen–brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation
Jingsi Yan, Jiayu Zhang, Xinyi Ye, Hao Wang, Hang Li, Weirong Li, Huifei Wu, Wei Zhao. Alzheimer s & Dementia, 2026-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Emerging evidence highlights the central role of peripheral immune-metabolic regulation in the pathogenesis of Alzheimer's disease and related dementias (ADRD). Among peripheral organs, the spleen has gained increasing attention as a critical immune-metabolic hub linking systemic homeostasis to central neurodegeneration. This review systematically elucidates the regulatory functions of the spleen-brain axis from three complementary perspectives: (1) structural remodeling and immunopathological alterations of the spleen in ADRD; (2) spleen-driven immunometabolic crosstalk, which integrates immune function with iron homeostasis, glucolipid metabolism, and amino acid turnover, contributing to the progression of neurodegenerative pathology; and (3) key molecular pathways mediating immune-metabolic crosstalk, such as Toll-like receptor 4 (TLR4)-nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), NLR family pyrin domain containing 3 (NLRP3) inflammasome, high-mobility group box 1 (HMGB1)-receptor for advanced glycation end-products (RAGE), and Janus kinase/signal transducer and activator of transcription protein (JAK/STAT) signaling. We systematically elucidate how splenic dysfunction drives a positive feedback loop involving systemic inflammation, metabolic disorder, and neuroinflammation. This novel perspective, which views the spleen as an integrated immune-metabolic regulator, highlights spleen-targeted interventions as a potential therapeutic strategy for ADRD.
What this study adds
Evidence grade: Low
This review proposes the spleen as an immune-metabolic hub whose dysfunction drives a feedback loop of systemic inflammation, metabolic disorder and neuroinflammation in Alzheimer's disease and related dementias. It is a review of a proposed mechanism and does not test any treatment, cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Yan, J., Zhang, J., Ye, X., Wang, H., Li, H., Li, W., et al. (2026). The spleen–brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation. Alzheimer s & Dementia. https://doi.org/10.1002/alz.71243
Vancouver
Yan J, Zhang J, Ye X, Wang H, Li H, Li W, et al. The spleen–brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation. Alzheimer s & Dementia. 2026. doi:10.1002/alz.71243. PMID: 41778859.
BibTeX
@article{yan2026-41778859,
author = {Yan, Jingsi and Zhang, Jiayu and Ye, Xinyi and Wang, Hao and Li, Hang and Li, Weirong and Wu, Huifei and Zhao, Wei},
title = {{The spleen–brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation}},
journal = {Alzheimer s \& Dementia},
year = {2026},
doi = {10.1002/alz.71243},
pmid = {41778859},
url = {https://doi.org/10.1002/alz.71243}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Emerging evidence highlights the central role of peripheral immune-metabolic regulation in the pathogenesis of Alzheimer's disease and related dementias (ADRD).
- Among peripheral organs, the spleen has gained increasing attention as a critical immune-metabolic hub linking systemic homeostasis to central neurodegeneration.
- This review systematically elucidates the regulatory functions of the spleen-brain axis from three complementary perspectives: (1) structural remodeling and immunopathological alterations of the spleen in ADRD; (2) spleen-driven immunometabolic crosstalk, which integrates immune function with iron homeostasis, glucolipid metabolism, and amino acid turnover, contributing to the progression of neurodegenerative pathology; and (3) key molecular pathways mediating immune-metabolic crosstalk, such as Toll-like receptor 4 (TLR4)-nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), NLR family pyrin domain containing 3 (NLRP3) inflammasome, high-mobility group box 1 (HMGB1)-receptor for advanced glycation end-products (RAGE), and Janus kinase/signal transducer and activator of transcription protein (JAK/STAT) signaling.
- We systematically elucidate how splenic dysfunction drives a positive feedback loop involving systemic inflammation, metabolic disorder, and neuroinflammation.
- This novel perspective, which views the spleen as an integrated immune-metabolic regulator, highlights spleen-targeted interventions as a potential therapeutic strategy for ADRD.
Why it matters
This review proposes the spleen as an immune-metabolic hub whose dysfunction drives a feedback loop of systemic inflammation, metabolic disorder and neuroinflammation in Alzheimer's disease and related dementias. It is a review of a proposed mechanism and does not test any treatment, cure or prevention.
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 34 of the 96 points we could judge it on, which is 35 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 5.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Wei Zhao holds only 1 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Guangzhou University of Chinese Medicine: institution h-index 248 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41778859) |
| Free to read | 2 / 2 | Free to read |
| Points | 34 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 34 of the 96 points we could judge it on is 35 out of 100. |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Disease mechanisms from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.